Loading, please wait ...


News Analytics

dementia 241431741.
Plasma biomarker assays for t-tau, NfL, GFAP and UCH-L1 demonstrated “a significant elevation” in patients with COVID-19 who had neurological symptoms compared with those with COVID-19 and no neurological symptoms: NfL (two-tailed t-test, P = .0003), GFAP (two-tailed t-test, P = .0098), UCH-L1 (two-tailed t-test, P = .0138) and t-tau (two-tailed t-test, P = .04).
Google

Subject Matter

  • Science and technology 66.25%
  • Healthcare 33.75%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions